U.S. Contraceptive Market Worth $11.6 Billion By 2025: Grand View Research, Inc.

Posted on
by

“Grand View Research, Inc. – Market Research And Consulting.”
According to report published by Grand View Research, increasing awareness about long-acting reversible contraceptive is expected to augment the product demand, thereby driving the U.S. contraceptive market over the next few years. Availability of various contraceptive options for both men and women and growing awareness about the use of contraceptive among teens in the region are also likely to fuel the U.S. contraceptive market.

According to a report,“U.S. Contraceptive Market Size, Share & Trends Analysis Report By Product (Pill, IUD, Diaphragm, Subdermal Implant, Condom, Vaginal Ring, Sponge, Injectable, Patch), And Segment Forecasts, 2018 – 2025”, published by Grand View Research, Inc., The U.S. contraceptive market size is expected to reach at USD 11.6 billion by 2025 expanding at a CAGR of 5.3% over the forecast period. Increasing awareness about long-acting reversible contraceptive is expected to augment the product demand, thereby driving the market over the next few years. Availability of various contraceptive options for both men and women and growing awareness about the use of contraceptive among teens in the region are also likely to fuel the U.S. contraceptive market.

Key Takeaways from the report:

  • Condom segment accounted for the second-largest share of the market. This can be attributed to its ability to provide protection against Sexually Transmitted Diseases (STDs)

  • Intrauterine Device (IUD) segment accounted for the significant share in 2017 and is expected to register a CAGR of 6.7% during the forecast period

  • Subdermal implant segment is expected to observe the fastest growth during the forecast period due to its 100% effectivity, easy insertion and removal mechanism, and ability to prevent pregnancy for 3 to 5 years

  • Some of the key companies in the U.S. contraceptive market are Mayer Laboratories, Inc.; Teva Pharmaceutical Industries Ltd.; Bayer AG, Reckitt Benckiser Plc; Pfizer, Inc.; Cooper Surgical, Inc.; Church & Dwight Co., Inc.; and Merck & Co.

U.S. contraceptive market size, by product, 2014 - 2025 (USD Billion)

Browse More Reports in pharmaceuticals: 

  • Urothelial Cancer Drugs: Availability of novel drugs, presence of a strong pipeline, rising disease incidence, unhealthy lifestyle, and increasing awareness are driving this urothelial cancer drugs market. 
  • Crohn’s Disease Therapeutics Market: Increasing awareness of the disease, coupled with rising initiatives by regulatory bodies for development of novel treatment options, is estimated to provide the crohn’s disease therapeutics market with high growth potential.

U.S. contraceptive market share, by product, 2017 (%)

Furthermore, recent mergers & acquisitions along with commercialization of newer drugs and devices are likely to propel the market growth over the forecast period. For instance, in July 2015, a new diaphragm, Caya, launched in U.S. after 50 years of gap. The device is 94% effective when used perfectly. Among different contraceptive product types, oral contraceptive pills accounted for the largest share of the regional market in 2017 mainly due to its effectiveness, easy availability, and low costs.

Grand View Research has segmented the U.S. contraceptive market on the basis of product:

U.S. Contraceptive Product Outlook (Revenue, USD Million, 2014 – 2025)

  • Pill

  • Condom

    • Male

    • Female

  • Diaphragm

  • Sponge

  • Vaginal Ring

  • Subdermal Implant

  • IUD 

    • Hormonal IUD

    • Nonhormonal IUD

  • Patch

  • Injectable

Explore the BI enabled intuitive market research database, Navigate with Grand View Compass, by Grand View Research, Inc.

About Grand View Research

Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.

For more information: www.grandviewresearch.com

Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:201, Spear Street, 1100
City: San Francisco
State: California
Country: United States
Website: www.grandviewresearch.com/industry-analysis/us-contraceptive-market